Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/102618
DC FieldValueLanguage
dc.contributor.authorRodrigues, Márcio-
dc.contributor.authorAlves, Gilberto-
dc.contributor.authorFrancisco, Joana-
dc.contributor.authorFortuna, Ana-
dc.contributor.authorFalcão, Amílcar-
dc.date.accessioned2022-10-04T10:37:14Z-
dc.date.available2022-10-04T10:37:14Z-
dc.date.issued2014-
dc.identifier.issn1482-1826pt
dc.identifier.issn1482-1826pt
dc.identifier.urihttps://hdl.handle.net/10316/102618-
dc.description.abstractPurpose - Carica papaya has been traditionally used worldwide in folk medicine to treat a wide range of ailments in humans, including the management of obesity and digestive disorders. However, scientific information about its potential to interact with conventional drugs is lacking. Thus, this work aimed to investigate the interference of a standardized C. papaya extract (GMP certificate) on the systemic exposure to amiodarone (a narrow therapeutic index drug) in rats. Methods - In the first pharmacokinetic study, rats were simultaneously co-administered with a single-dose of C. papaya (1230 mg/kg, p.o.) and amiodarone (50 mg/kg, p.o.); in the second study, rats were pre-treated for 14 days with C. papaya (1230 mg/kg/day, p.o.) and received amiodarone (50 mg/kg, p.o.) on the 15th day. Rats of the control groups received the herbal extract vehicle. Blood samples were collected before dosing and at 0.25, 0.5, 1, 2, 4, 6, 8 and 12 h following amiodarone administration; in addition, at 24 h post-dose, blood and tissues (heart, liver, kidneys and lungs) were also harvested. Thereafter, the concentrations of amiodarone and its major metabolite (mono-N-desethylamiodarone) were determined in plasma and tissue samples employing a highperformance liquid chromatography-diode array detection method previously developed and validated. Results - In both studies was observed a delay in attaining the maximum plasma concentrations of amiodarone (tmax) in the rats treated with the extract. Nevertheless, it must be highlighted the marked increase (60-70%) of the extent of amiodarone systemic exposure (as assessed by AUC0-t and AUC0-∞) in the rats pre-treated with C. papaya comparatively with the control (vehicle) group. Conclusions – The results herein found suggest an herb-drug interaction between C. papaya extract and amiodarone, which clearly increase the drug bioavailability. To reliably assess the clinical impact of these findings appropriate human studies should be conducted.pt
dc.language.isoengpt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/pt
dc.titleHerb-drug Pharmacokinetic Interaction between Carica Papaya Extract and Amiodarone in Ratspt
dc.typearticle-
degois.publication.firstPage302pt
degois.publication.lastPage315pt
degois.publication.issue3pt
degois.publication.titleJournal of Pharmacy and Pharmaceutical Sciencespt
dc.peerreviewedyespt
dc.identifier.doi10.18433/J3559Npt
degois.publication.volume17pt
dc.date.embargo2014-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.orcid0000-0002-3854-6549-
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
FFUC- Artigos em Revistas Internacionais
Show simple item record

WEB OF SCIENCETM
Citations

9
checked on May 2, 2024

Page view(s)

59
checked on May 7, 2024

Download(s)

50
checked on May 7, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons